已发表论文

胰岛素与 C 肽摩尔比(ICPR)在 2 型糖尿病患者胰岛素抗体初筛中的应用:ICPR 与胰岛素抗体关系的进一步定量研究

 

Authors Hua KF , Jing BY , Wu YH 

Received 20 January 2023

Accepted for publication 15 April 2023

Published 22 April 2023 Volume 2023:16 Pages 1121—1132

DOI https://doi.org/10.2147/DMSO.S404222

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Konstantinos Tziomalos

Purpose: This study aimed to further quantify the relationship between insulin antibodies (IAs) and the 2-hour insulin to C-peptide molar ratio (2h-ICPR) using a multiple linear regression model in T2DM patients.
Methods: A total of 274 T2DM patients from April 2019 to December 2022 in Xiang’an Hospital of Xiamen University were included in this study. Multiple Linear Model Fitting was conducted on the candidate independent variables (age, BMI, HbA1c, and 2h-ICPR) for the multiple linear regression. The linear relationship between insulin antibodies (IAs) and the significant independent variables was presented by making multiple linear regression equations.
Results: The total demographic characteristics of the included patients were as follows: age (51.92± 13.10 years), BMI (24.94± 3.99 kg/m2), HbA1c (9.70± 2.39%), 2h-ICPR (0.12± 0.11), and IAs (0.37± 1.12COI). Linear relationships of independent variables: age (=0.163, p=0.007), 2h-ICPR (=0.259, p=0.001), BMI (=0.007, p=0.907) and 2h-ICPR (=0.092, p=0.129). Multiple linear regression: age (unstandardized β=0.014, 95% CI: 0.004– 0.024, p=0.004), 2h-ICPR (unstandardized β=2.758, 95% CI: 1.555– 3.962, p≤ 0.001).
Conclusion: 2h-ICPR can be a preliminary screening indicator for insulin antibody testing in patients with type 2 diabetes.
Keywords: insulin, insulin antibodies, C-peptide, multiple linear regression model